Journal: Neuropsychobiology

Submission Deadline: June 30, 2025

The Neuropsychobiology journal aims to provide a comprehensive overview of lithium’s journey over the past fifty years, as well as present and discuss current challenges and future improvements. The goal is to highlight both the scientific advancements, and the practical hurdles associated with this remarkable element. 

Lithium has been a cornerstone in the treatment of bipolar disorder since its discovery in the late 1940. Over the past fifty years, lithium has remained a gold standard in psychiatric medicine due to its ability to reduce the frequency and severity of manic and depressive episodes. However, lithium therapy patients often require regular blood tests to monitor lithium levels due to its narrow therapeutic window. Additionally, long-term use can lead to side effects such as kidney and thyroid issues. Research continues to explore ways to enhance lithium’s efficacy and safety. 

Topics of particular interest for the article collection on ‘Exploring Lithium in Psychiatry and Beyond’ are:  

  • Mechanisms of action 
  • Side Effects and management, including improvement of patient compliance 
  • Clinical innovations, including innovations in drug delivery systems 
  • Neurobiological background 

Please select the option “Call for Papers: Exploring Lithium in Psychiatry and Beyond” when submitting your manuscript and mention this Call for Papers in your cover letter. 

Neuropsychobiology supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Check out the Author Guidelines.

SUBMIT NOW